Pharmaceutical supply chains in North America remain highly dependent on overseas manufacturing. Most critical active pharmaceutical ingredients (APIs) and fine chemicals essential for drug production are imported, making the region vulnerable to disruptions in global supply chains. Our initiative aims to strengthen pharmaceutical independence by developing local, sustainable, and innovative solutions. Our dedicated team of […]
Read More